SEARCH

Search Details

YOSHIDA Toshihiko
University Hospital / Hepato-Biliary-Pancreatic Surgery
Assistant Professor

Researcher basic information

■ Research Areas
  • Other / Other

Research activity information

■ Paper
  • 【肝癌診療2024】肝細胞癌集学的治療の進歩
    小松 昇平, 木戸 正浩, 権 英寿, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 田井 謙太郎, 荒井 啓輔, 柳本 泰明, 外山 博近, 福本 巧
    (株)へるす出版, Sep. 2024, 消化器外科, 47(9) (9), 1059 - 1070, Japanese

  • Kentaro Oji, Takeshi Urade, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Nobuaki Yamasaki, Kenji Fukushima, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Masayuki Akita, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    PURPOSE: The technical difficulties of laparoscopic liver resection (LLR) are greatly associated with the location of liver tumors. Since segment 8 (S8) contains a wide area, the difficulty of LLR for S8 tumors may vary depending on the location within the segment, such as the ventral (S8v) and dorsal (S8d) area, but the difference is unclear. METHODS: We retrospectively investigated 30 patients who underwent primary laparoscopic partial liver resection for liver tumors in S8 at Kobe University Hospital between January 2018 and June 2023. RESULTS: Thirteen and 17 patients underwent LLR for S8v and S8d, respectively. The operation time was significantly longer (S8v 203[135-259] vs. S8d 261[186-415] min, P = 0.002) and the amount of blood loss was significantly higher (10[10-150] vs. 10[10-200] mL, P = 0.034) in the S8d group than in the S8v group. No significant differences were observed in postoperative complications or postoperative length of hospital stay. Additionally, intraoperative findings revealed that the rate at which the case performed partial liver mobilization in the S8d group was higher (2[15.4%] vs. 8[47.1%], P = 0.060) and the median parenchymal transection time of the S8d group was longer (102[27-148] vs. 129[37-175] min, P = 0.097) than those in the S8v group, but there were no significant differences. CONCLUSION: The safety of LLR for the S8d was comparable to that of LLR for S8v, although LLR for S8d resulted in longer operative time and more blood loss. THE TRIAL REGISTRATION NUMBER: B230165 (approved at December 26, 2023).
    Aug. 2024, Langenbeck's archives of surgery, 409(1) (1), 243 - 243, English, International magazine
    Scientific journal

  • 吉田 道彦, 柳本 泰明, 津川 大介, 秋田 真之, 藤田 千佳, 吉田 俊彦, 宗 慎一, 石田 潤, 南野 佳英, 浦出 剛史, 福島 健司, 権 英寿, 小松 昇平, 浅利 貞毅, 児玉 貴之, 木戸 正浩, 外山 博近, 神保 直江, 伊藤 智雄, 福本 巧
    日本膵・胆管合流異常研究会, Aug. 2024, 日本膵・胆管合流異常研究会プロシーディングス, 47, 16 - 16, Japanese

  • Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, Motofumi Tanaka, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Masahiro Kido, Takumi Fukumoto
    PURPOSE: The impact of postoperative bile leak on the prognosis of patients with hepatocellular carcinoma who underwent liver resection is controversial. This study aimed to investigate the prognostic impact of bile leak for patients with hepatocellular carcinoma who underwent liver resection. METHODS: Patients with hepatocellular carcinoma who underwent liver resection between 2009 and 2019 at Kobe University Hospital and Hyogo Cancer Center were included. After propensity score matching between the bile leak and no bile leak groups, differences in 5-year recurrence-free and overall survival rates were evaluated using the Kaplan-Meier method. RESULTS: A total of 781 patients, including 43 with postoperative bile leak, were analyzed. In the matched cohort, 40 patients were included in each group. The 5-year recurrence-free survival rates after liver resection were 35% and 32% for the bile leak and no bile leak groups, respectively (P = 0.857). The 5-year overall survival rates were 44% and 54% for the bile leak and no bile leak groups, respectively (P = 0.216). CONCLUSION: Overall, bile leak may not have a profound negative impact on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection.
    Jul. 2024, Langenbeck's archives of surgery, 409(1) (1), 233 - 233, English, International magazine
    Scientific journal

  • Nobuaki Ishihara, Shohei Komatsu, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Keisuke Arai, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    Tremelimumab plus durvalumab (Dur/Tre) is the first-line treatment for advanced hepatocellular carcinoma (HCC) worldwide. The present report describes the case of a 68-year-old man diagnosed with advanced HCC and a bile duct tumor thrombus (BDTT) who achieved a complete response to Dur/Tre therapy. The BDTT progressed to the bifurcation of the left and right hepatic ducts. Over time, both the tumors and BDTT progressively decreased in size, and a complete response was confirmed using the Response Evaluation Criteria in Solid Tumors (version 1.1.) 6 months after treatment administration. Subsequently, immune-related adverse events, including type 1 diabetes mellitus and diabetic ketoacidosis, emerged, leading to treatment discontinuation. The patient was undergoing outpatient follow-up in a drug-free state with no signs of recurrence 290 days after the initial administration of Dur/Tre. Although long-term and meticulous observations are required, the present findings could influence the choice of systemic chemotherapy for advanced HCC.
    Jul. 2024, Oncology letters, 28(1) (1), 332 - 332, English, International magazine
    Link to Kobe Univ. Repository (Kernel)

  • Akira Koizumi, Shohei Komatsu, Satoshi Omiya, Yoshihiko Yano, Yoshimi Fujishima, Jun Ishida, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Ryosuke Fujinaka, Yuhi Shimura, Hiroaki Yanagimoto, Hirochika Toyama, Yoshihide Ueda, Yuzo Kodama, Takumi Fukumoto
    BACKGROUND/AIM: The treatment algorithm for systemic therapies for advanced hepatocellular carcinoma (HCC) has changed dramatically; however, the therapeutic landscape for sequential second-line or later-line treatments, including ramucirumab, remains controversial. This study aimed to investigate the role of ramucirumab for treating HCC. PATIENTS AND METHODS: We retrospectively analyzed data from 17 patients with advanced HCC who received ramucirumab, and 8 of them who received lenvatinib re-administration after ramucirumab treatment failure. RESULTS: The median overall survival of 17 patients treated with ramucirumab was 11.5 months. The median ratios of the 1-month post-treatment α-fetoprotein (AFP) levels and albumin-bilirubin (ALBI) scores to the pre-treatment AFP levels and ALBI scores following ramucirumab treatment were 0.880 and 0.965, respectively. The median ratios of the 1-month post-treatment AFP and ALBI levels to the pre-treatment levels were 1.587 and 0.970 for mALBI grade 1/2a, and 1.313 and 0.936 for mALBI grade 2b/3, respectively. Six of the eight patients who received lenvatinib rechallenge treatment exhibited a decrease in AFP levels one month post-lenvatinib treatment. Deterioration of liver function 3 months post-lenvatinib treatment was noted in five of the eight patients who received lenvatinib rechallenge treatment after ramucirumab. CONCLUSION: Ramucirumab may be equally useful in patients with unresectable HCC who have poor liver function or whose liver function is aggravated by other therapies. Rechallenge treatment with lenvatinib after ramucirumab may be a valid treatment option for HCC.
    May 2024, Anticancer research, 44(5) (5), 2055 - 2061, English, International magazine
    Scientific journal

  • Hidetoshi Gon, Shohei Komatsu, Satoshi Omiya, Masahiro Kido, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    BACKGROUND/AIM: This study aimed to evaluate the utility of the albumin-bilirubin grade for predicting the prognosis after repeat liver resection for patients with recurrent hepatocellular carcinoma. PATIENTS AND METHODS: Ninety patients with intrahepatic recurrent hepatocellular carcinoma who underwent repeat liver resection at our institution between 2005 and 2019 were retrospectively analyzed. Cox proportional-hazards regression models evaluated independent preoperative prognostic factors, including the albumin-bilirubin grade. Prognosis differences between patients with albumin-bilirubin grades 1 and 2 were analyzed using the Kaplan-Meier method. RESULTS: Cox proportional-hazards regression analysis revealed that albumin-bilirubin grade 2 (p=0.003) and early recurrence within one year from the initial surgery (p=0.001) were independently associated with poor recurrence-free survival, and albumin-bilirubin grade 2 (p=0.020) was independently associated with poor overall survival. The five-year recurrence-free (31% and 17%, respectively) and overall (86% and 60%, respectively) survival rates after repeat liver resection for patients with albumin-bilirubin grades 1 and 2 were significantly different between groups (both p=0.003). CONCLUSION: The albumin-bilirubin grade is useful for preoperatively predicting favorable survival rates after repeat liver resection for patients with recurrent hepatocellular carcinoma. Patients with an albumin-bilirubin grade 1 are better candidates for surgical treatment of recurrent hepatocellular carcinoma.
    May 2024, Anticancer research, 44(5) (5), 2031 - 2038, English, International magazine
    Scientific journal

  • Jun Ishida, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Yoshihide Nanno, Toshihiko Yoshida, Shinichi So, Takeshi Urade, Kenji Fukushima, Hidetoshi Gon, Daisuke Tsugawa, Shohei Komatsu, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto
    BACKGROUND: Drainage fluid amylase (DFA) is useful for predicting clinically relevant postoperative pancreatic fistula (CR-POPF) after distal pancreatectomy (DP). However, difference in optimal cutoff value of DFA for predicting CR-POPF between open DP (ODP) and laparoscopic DP (LDP) has not been investigated. This study aimed to identify the optimal cutoff values of DFA for predicting CR-POPF after ODP and LDP. METHODS: Data for 294 patients (ODP, n = 127; LDP, n = 167) undergoing DP at Kobe University Hospital between 2010 and 2021 were reviewed. Propensity score matching was performed to minimize treatment selection bias. Receiver operating characteristic (ROC) analysis was performed to determine the optimal cutoff values of DFA for predicting CR-POPF for ODP and LDP. Logistic regression analysis for CR-POPF was performed to investigate the diagnostic value of DFA on postoperative day (POD) three with identified cutoff value. RESULTS: In the matched cohort, CR-POPF rates were 24.7% and 7.9% after ODP and LDP, respectively. DFA on POD one was significantly lower after ODP than after LDP (2263 U/L vs 4243 U/L, p < 0.001), while the difference was not significant on POD three (543 U/L vs 1221 U/L, p = 0.171). ROC analysis revealed that the optimal cutoff value of DFA on POD one and three for predicting CR-POPF were different between ODP and LDP (ODP, 3697 U/L on POD one, 1114 U/L on POD three; LDP, 10564 U/L on POD one, 6020 U/L on POD three). Multivariate analysis showed that DFA on POD three with identified cutoff value was the independent predictor for CR-POPF both for ODP and LDP. CONCLUSIONS: DFA on POD three is an independent predictor for CR-POPF after both ODP and LDP. However, the optimal cutoff value for it is significantly higher after LDP than after ODP. Optimal threshold of DFA for drain removal may be different between ODP and LDP.
    Mar. 2024, Surgical endoscopy, 38(5) (5), 2699 - 2708, English, International magazine
    Scientific journal

  • Taiichiro Miyake, Hiroaki Yanagimoto, Daisuke Tsugawa, Masayuki Akita, Riki Asakura, Keisuke Arai, Toshihiko Yoshida, Shinichi So, Jun Ishida, Takeshi Urade, Yoshihide Nanno, Kenji Fukushima, Hidetoshi Gon, Shohei Komatsu, Sadaki Asari, Hirochika Toyama, Masahiro Kido, Tetsuo Ajiki, Takumi Fukumoto
    BACKGROUND: Venous thromboembolism (VTE) is a potentially fatal complication of hepatectomy. The use of postoperative prophylactic anticoagulation in patients who have undergone hepatectomy is controversial because of the risk of postoperative bleeding. Therefore, we hypothesized that monitoring plasma D-dimer could be useful in the early diagnosis of VTE after hepatectomy. AIM: To evaluate the utility of monitoring plasma D-dimer levels in the early diagnosis of VTE after hepatectomy. METHODS: The medical records of patients who underwent hepatectomy at our institution between January 2017 and December 2020 were retrospectively analyzed. Patients were divided into two groups according to whether or not they developed VTE after hepatectomy, as diagnosed by contrast-enhanced computed tomography and/or ultrasonography of the lower extremities. Clinicopathological factors, including demographic data and perioperative D-dimer values, were compared between the two groups. Receiver operating characteristic curve analysis was performed to determine the D-dimer cutoff value. Univariate and multivariate analyses were performed using logistic regression analysis to identify significant predictors. RESULTS: In total, 234 patients who underwent hepatectomy were, of whom (5.6%) were diagnosed with VTE following hepatectomy. A comparison between the two groups showed significant differences in operative time (529 vs 403 min, P = 0.0274) and blood loss (530 vs 138 mL, P = 0.0067). The D-dimer levels on postoperative days (POD) 1, 3, 5, 7 were significantly higher in the VTE group than in the non-VTE group. In the multivariate analysis, intraoperative blood loss of > 275 mL [odds ratio (OR) = 5.32, 95% confidence interval (CI): 1.05-27.0, P = 0.044] and plasma D-dimer levels on POD 5 ≥ 21 μg/mL (OR = 10.1, 95%CI: 2.04-50.1, P = 0.0046) were independent risk factors for VTE after hepatectomy. CONCLUSION: Monitoring of plasma D-dimer levels after hepatectomy is useful for early diagnosis of VTE and may avoid routine prophylactic anticoagulation in the postoperative period.
    Jan. 2024, World journal of clinical cases, 12(2) (2), 276 - 284, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Nobuaki Yamasaki, Hidetoshi Gon, Hisoka Yamane, Toshihiko Yoshida, Hirotoshi Soyama, Masahiro Kido, Motofumi Tanaka, Shohei Komatsu, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    BACKGROUND: The safety and efficacy of laparoscopic liver resection (LLR) have been reported worldwide. However, those of LLR for tumors located in Couinaud's segment 8 are not sufficiently investigated. METHODS: We retrospectively analyzed 108 patients who underwent liver resection for hepatocellular carcinoma (HCC) in segment 8 at Kobe University Hospital and Hyogo Cancer Center between January 2010 and December 2021. The patients were categorized in LLR and open liver resection (OLR) groups, and 1:1 propensity score matching (PSM) was performed to compare surgical outcomes between the groups. RESULTS: Forty-seven and 61 patients underwent LLR and OLR, respectively. After PSM, each group contained 34 patients. There was no significant difference in operation time between the groups (331 min vs. 330 min, P = 0.844). Patients in the LLR group had significantly less blood loss (30 mL vs. 468 mL, P < 0.001) and shorter length of postoperative hospital stay (10 days vs. 12 days, P = 0.015) than those in the OLR group. There was no significant difference in the occurrence of postoperative complications between the groups (12% vs. 9%, P = 0.690). Further, the 1-year cumulative incidence of recurrence was not significantly different between the groups (16% vs. 19%, P = 0.734). CONCLUSIONS: The surgical outcomes and short-term prognosis of LLR were similar or better than those of OLR. LLR could be an effective and safe procedure, even for lesions located in segment 8, which is considered a difficult anatomical location for LLR.
    Nov. 2023, Surgical endoscopy, 37(11) (11), 8438 - 8446, English, International magazine
    Scientific journal

  • Hidetoshi Gon, Shohei Komatsu, Masahiro Kido, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    BACKGROUND: Less intra-abdominal adhesions are expected following laparoscopic surgery. Although an initial laparoscopic approach for primary liver tumors may have advantages in patients who require repeat hepatectomies for recurrent liver tumors, this has not been sufficiently investigated. METHODS: Patients who underwent repeat hepatectomies for recurrent liver tumors at our hospital between 2010 and 2022 were retrospectively analyzed. Of 127 patients, 76 underwent laparoscopic repeat hepatectomy (LRH), of whom 34 patients initially underwent laparoscopic hepatectomy (L-LRH) and 42, open hepatectomy (O-LRH). Fifty-one patients underwent open hepatectomy as both the initial and second operation (O-ORH). We analyzed surgical outcomes between L-LRH and O-LRH groups and between L-LRH and O-ORH groups using propensity-matching analysis for each pattern. RESULTS: Twenty-one patients each were included in L-LRH and O-LRH propensity-matched cohorts. The L-LRH group had a lower rate of postoperative complications than the O-LRH group (0 vs 19%, P = 0.036). When we compared surgical outcomes between L-LRH and O-ORH groups in another matched cohort with 18 patients in each group, in addition to the lower rate of postoperative complications, the L-LRH group had additional favorable surgical outcomes including shorter operation time and lower blood loss volume than the O-ORH group (291 vs 368 min, P = 0.037 and 10 vs 485 mL, P < 0.0001). CONCLUSIONS: An initial laparoscopic approach would be favorable for patients undergoing repeat hepatectomies, as it leads to lower risk of postoperative complications. Compared with O-ORH, the advantage of the laparoscopic approach may be enhanced when it is repeatedly adopted.
    Aug. 2023, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 27(8) (8), 1621 - 1631, English, International magazine
    Scientific journal

  • Yuhi Shimura, Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Daisuke Tsugawa, Tadahiro Goto, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Tetsuo Ajiki, Takumi Fukumoto
    BACKGROUND: Post-transplantation weight control is important for long-term outcomes; however, few reports have examined postoperative weight change. This study aimed to identify perioperative factors contributing to post-transplantation weight change. METHODS: Twenty-nine patients who underwent liver transplantation between 2015 and 2019 with an overall survival of >3 years were analyzed. RESULTS: The median age, model for end-stage liver disease score, and preoperative body mass index (BMI) of the recipients were 57, 25, and 23.7, respectively. Although all but one recipient lost weight, the percentage of recipients who gained weight increased to 55% (1 month), 72% (6 months), and 83% (12 months). Among perioperative factors, recipient age ≤50 years and BMI ≤25 were identified as risk factors for weight gain within 12 months (P < .05), and patients with age ≤50 years or BMI ≤25 recipients gained weight more rapidly (P < .05). The recovery time of serum albumin level ≥4.0 mg/dL was not statistically different between the 2 groups. The weight change during the first 3 years after discharge was represented by an approximately straight line, with 18 and 11 recipients showing a positive and negative slope, respectively. Body mass index ≤23 was identified as a risk factor for a positive slope of weight gain (P <.05). CONCLUSIONS: Although postoperative weight gain implies recovery after transplantation, recipients with a lower preoperative BMI should strictly manage body weight as they may be at higher risk of rapid weight increase.
    May 2023, Transplantation proceedings, 55(4) (4), 924 - 929, English, International magazine
    Scientific journal

  • 古谷 晃伸, 福岡 英志, 毛利 康一, 吉田 俊彦, 秋山 真吾, 山岸 農, 村田 晃一, 大坪 大, 山根 秘我, 沢 秀博, 田中 基文, 鈴木 知志, 藤野 泰宏, 富永 正寛
    (株)癌と化学療法社, Feb. 2023, 癌と化学療法, 50(2) (2), 221 - 223, Japanese

  • Hidetoshi Gon, Hisoka Yamane, Toshihiko Yoshida, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Shohei Komatsu, Kenji Fukushima, Takeshi Urade, Shinichi So, Yoshihide Nanno, Daisuke Tsugawa, Tadahiro Goto, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto
    BACKGROUND: Resecting liver tumors located in Couinaud's segment VII is challenging; the efficacy and safety of laparoscopic liver resection for segment VII lesions compared to open liver resection remain unclear. METHODS: Medical records of 84 patients who underwent liver resection of segment VII at Kobe University Hospital and Hyogo Cancer Center between 2010 and 2021 were retrospectively analyzed. Surgical outcomes were compared between laparoscopic liver resection and open liver resection groups using propensity matching analysis. RESULTS: Thirty-one and 53 patients underwent laparoscopic liver resection and open liver resection, respectively. After propensity matching, 29 patients were included in each group. The laparoscopic liver resection group had a significantly longer operation time (407 vs. 305 min, P = 0.002), lower blood loss (100 vs. 230 mL, P = 0.004), and higher postoperative alanine aminotransferase levels (436 vs. 252 IU/L, P = 0.008) than the open liver resection group. In patients with liver cirrhosis, the proportion of patients with postoperative liver-specific complications was higher in the laparoscopic liver resection group than in the open liver resection group (57% vs 11%, P = 0.049), although there was no significant difference in postoperative liver-specific complication rates between the groups in patients without liver cirrhosis. CONCLUSIONS: For liver resection of segment VII, laparoscopic liver resection led to higher postoperative liver damage than open liver resection. Open liver resection may be better for patients with liver cirrhosis to avoid postoperative liver-specific complications. Laparoscopic liver resection could be an acceptable procedure for patients without liver cirrhosis, with some merits such as less blood loss.
    Nov. 2022, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 26(11) (11), 2274 - 2281, English, International magazine
    Scientific journal

  • Taku Matsumoto, Toshihiko Yoshida, Takashi Yamagishi, Hironobu Goto, Dai Otsubo, Akinobu Furutani, Hisoka Yamane, Yasuhiro Fujino, Masahiro Tominaga
    We should know that hepatocellular carcinoma can progress as if it replaces the bile duct wall itself.
    Mar. 2021, Clinical case reports, 9(3) (3), 1561 - 1565, English, International magazine

  • Takeshi Urade, Toshihiko Yoshida, Naoko Ikeo, Kosuke Naka, Masahiro Kido, Hirochika Toyama, Kimihiko Ueno, Motofumi Tanaka, Toshiji Mukai, Takumi Fukumoto
    BACKGROUND: The use of surgical metal clips is crucial for ligating vessels in various operations. The currently available metal clips have several drawbacks; they are permanent and interfere with imaging techniques such as computed tomography (CT) or magnetic resonance (MR) imaging and carry the potential risk of endo-clip migration. We recently developed a novel magnesium (Mg) alloy for biodegradable clips that reduces artifacts on CT imaging. This study aimed to examine the tolerance, biodegradability, and biocompatibility of the Mg alloy clips compared with those of standard titanium (Ti) clips in hepatectomy. METHODS: Thirty Wistar rats were divided into two groups based on the clip used (groups A and B). The vascular pedicle, including hepatic artery, portal vein, bile duct, and hepatic vein of the left lateral lobe, was ligated with the Ti clip in group A or the Mg alloy clip in group B, and then the left lateral lobe was removed. The rats were sacrificed at 1, 4, 12, 24, and 36 weeks after surgery. Clinical and histological evaluations were performed. Absorption rate was calculated by measuring the clip volume. RESULTS: Although the Mg alloy clips showed biodegradability over time, there were no significant differences in the serum concentration of Mg between the two groups. The remaining volume ratio of Mg alloy clips was 95.5, 94.3, 80.0, 36.2, and 16.7% at 1, 4, 12, 24, and 36 weeks, respectively. No side effects occurred. Most of the microscopic changes were similar in both groups. CONCLUSIONS: The new biodegradable Mg alloy clips are safe and feasible in vessel ligation for hepatectomy in a rat model and reduce artifacts in CT imaging compared with the standard Ti clips.
    Sep. 2019, BMC surgery, 19(1) (1), 130 - 130, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Hisoka Yamane, Sachiko Yoshida, Toshihiko Yoshida, Masayasu Nishi, Takashi Yamagishi, Hironobu Goto, Dai Otsubo, Akinobu Furutani, Taku Matsumoto, Yasuhiro Fujino, Masahiro Tominaga
    We report a case of laparoscopic anatomical segment 3 segmentectomy for hepatocellular carcinoma (HCC) accompanied by hypoplasia of the right hepatic lobe. An 80-year-old man was admitted with a suspicion of HCC diagnosed by computed tomography during follow-up for thyroid cancer. Dynamic computed tomography showed 40-mm HCC in segment 3 and hypoplasia of the right hepatic lobe with the Chilaiditi sign. We performed laparoscopic anatomical segment 3 segmentectomy. There were no postoperative complications, and the patient was discharged 6 days postoperatively. This procedure can be performed safely and is technically feasible, but special attention should be paid to anatomical alterations to avoid fatal surgical complications.
    Jul. 2019, Journal of surgical case reports, 2019(7) (7), rjz213, English, International magazine

  • Takeshi Harada, Shinji Matsumoto, Suguru Hirota, Hirokazu Kimura, Shinsuke Fujii, Yuuya Kasahara, Hidetoshi Gon, Toshihiko Yoshida, Tomoo Itoh, Naotsugu Haraguchi, Tsunekazu Mizushima, Takehiro Noda, Hidetoshi Eguchi, Satoshi Nojima, Eiichi Morii, Takumi Fukumoto, Satoshi Obika, Akira Kikuchi
    ADP-ribosylation factor-like 4c (ARL4C) is identified as a small GTP-binding protein, which is expressed by Wnt and EGF signaling and plays an important role in tubulogenesis of cultured cells and the ureters. ARL4C is little expressed in adult tissues, but it is highly expressed in lung cancer and colorectal cancer and shown to represent a molecular target for cancer therapy based on siRNA experiments. This study revealed that ARL4C is highly expressed in primary hepatocellular carcinoma (HCC) tumors and colorectal cancer liver metastases, and that ARL4C expression is associated with poor prognosis for these cancers. Chemically modified antisense oligonucleotides (ASO) against ARL4C effectively reduced ARL4C expression in both HCC and colorectal cancer cells and inhibited proliferation and migration of these cancer cells in vitro ARL4C ASOs decreased the PIK3CD mRNA levels and inhibited the activity of AKT in HCC cells, suggesting that the downstream signaling of ARL4C in HCC cells is different from that in lung and colon cancer cells. In addition, subcutaneous injection of ARL4C ASO was effective in reducing the growth of primary HCC and metastatic colorectal cancer in the liver of immunodeficient mice. ARL4C ASO accumulated in cancer cells more efficiently than the surrounding normal cells in the liver and decreased ARL4C expression in the tumor. These results suggest that ARL4C ASO represents a novel targeted nucleic acid medicine for the treatment of primary and metastatic liver cancers.
    Mar. 2019, Molecular cancer therapeutics, 18(3) (3), 602 - 612, English, International magazine
    Scientific journal

  • Hisoka Yamane, Sachiko Yoshida, Toshihiko Yoshida, Masayasu Nishi, Takashi Yamagishi, Hironobu Goto, Dai Otsubo, Akinobu Furutani, Taku Matsumoto, Yasuhiro Fujino, Kazuyoshi Kajimoto, Toshiko Sakuma, Masahiro Tominaga
    INTRODUCTION: Lung large-cell neuroendocrine carcinoma (LCNEC) is an aggressive and a rare type of lung cancer, and the prognosis of LCNEC with distant metastasis is extremely poor, with a five-year survival rate of 0%. Here, we report a case of laparoscopic hepatectomy for liver metastasis of lung LCNEC. PRESENTATION OF CASE: A 63-year-old man received a routine physical examination, and abnormal chest radiographic findings were observed; chest computed tomography (CT) in our hospital revealed that the patient had left pneumothorax and a lesion measuring 18 mm in the inferior lingular segment of the lung. The patient underwent thoracoscopic lobectomy, and the final pathological diagnosis was lung LCNEC. Four years after surgery, abdominal CT revealed a mass measuring 27 mm in the liver. The patient underwent laparoscopic partial hepatectomy, and postoperative pathological examination showed liver metastasis of LCNEC. There was no sign of recurrence 6 months after hepatectomy. DISCUSSION: LCNEC with distant metastasis has a poor response to systemic chemotherapy, and the median survival time of patients with distant metastasis is estimated to be approximately 6 months, with a five-year survival rate of 0%. Although the common site of metastasis from LCNEC is the liver, there are no previous reports of hepatectomy for liver metastasis of LCNEC. CONCLUSION: We report a case of laparoscopic hepatectomy for liver metastasis of lung LCNEC. It is suggested that surgical resection for solitary distant metastasis of LCNEC may improve prognosis.
    2019, International journal of surgery case reports, 65, 40 - 43, English, International magazine
    Scientific journal

  • 消化器外科の診断・手技・治療に役立つ先進技術 マグネシウム合金を用いた新規生体吸収性外科クリップの開発 イヌ胆嚢摘出モデルでの安全性と忍容性の検討
    吉田 俊彦, 福本 巧, 浦出 剛史, 木戸 正浩, 外山 博近, 浅利 貞毅, 味木 徹夫, 池尾 直子, 向井 敏司, 具 英成
    (一社)日本消化器外科学会, Jul. 2017, 日本消化器外科学会総会, 72回, O3 - 6, Japanese

  • Toshihiko Yoshida, Takumi Fukumoto, Takeshi Urade, Masahiro Kido, Hirochika Toyama, Sadaki Asari, Tetsuo Ajiki, Naoko Ikeo, Toshiji Mukai, Yonson Ku
    BACKGROUND: Operative clips used to ligate vessels in abdominal operation usually are made of titanium. They remain in the body permanently and form metallic artifacts in computed tomography images, which impair accurate diagnosis. Although biodegradable magnesium instruments have been developed in other fields, the physical properties necessary for operative clips differ from those of other instruments. We developed a biodegradable magnesium-zinc-calcium alloy clip with good biologic compatibility and enough clamping capability as an operative clip. In this study, we verified the safety and tolerability of this clip for use in canine cholecystectomy. METHODS: Nine female beagles were used. We performed cholecystectomy and ligated the cystic duct by magnesium alloy or titanium clips. The chronologic change of clips and artifact formation were compared at 1, 4, 12, 18, and 24 weeks postoperative by computed tomography. The animals were killed at the end of the observation period, and the clips were removed to evaluate their biodegradability. We also evaluated their effect on the living body by blood biochemistry data. RESULTS: The magnesium alloy clip formed much fewer artifacts than the titanium clip, and it was almost absorbed at 6 months postoperative. There were no postoperative complications and no elevation of constituent elements such as magnesium, calcium, and zinc during the observation period in both groups. CONCLUSION: The novel magnesium alloy clip demonstrated sufficient sealing capability for the cystic duct and proper biodegradability in canine models. The magnesium alloy clip revealed much fewer metallic artifacts in CT than the conventional titanium clip.
    Jun. 2017, Surgery, 161(6) (6), 1553 - 1560, English, International magazine
    Scientific journal

  • 新規マグネシウム合金を用いた生体吸収性外科クリップの開発
    吉田 俊彦, 福本 巧, 味木 徹夫, 木戸 正浩, 外山 博近, 浅利 貞毅, 浦出 剛史, 池尾 直子, 向井 敏司, 具 英成
    (一社)日本消化器外科学会, Jul. 2016, 日本消化器外科学会総会, 71回, P1 - 10, Japanese

  • Low-Dose Antiviral Treatment for Hepatitis C Virus Following Living Donor Liver Transplantation without Splenectomy
    Toshihiko Yoshida, Atsushi Takebe, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shinichi So, Keisuke Arai, Yonson Ku
    May 2016, TRANSPLANTATION, 100, S211 - S211, English

  • Naoko Ikeo, Ryota Nakamura, Kosuke Naka, Toshiaki Hashimoto, Toshihiko Yoshida, Takeshi Urade, Kenji Fukushima, Hikaru Yabuuchi, Takumi Fukumoto, Yonson Ku, Toshiji Mukai
    UNLABELLED: To develop a biodegradable clip, the equivalent plastic strain distribution during occlusion was evaluated by the finite element analysis (FEA) using the material data of pure Mg. Since the FEA suggested that a maximum plastic strain of 0.40 is required to allow the Mg clips, the alloying of magnesium with essential elements and the control of microstructure by hot extrusion and annealing were conducted. Mechanical characterization revealed that the Mg-Zn-Ca alloy obtained by double extrusion followed by annealing at 673K for 2h possessed a fracture strain over 0.40. The biocompatibility of the alloy was confirmed here by investigating its degradation behavior and the response of extraperitoneal tissue around the Mg-Zn-Ca alloy. Small gas cavity due to degradation was observed following implantation of the developed Mg-Zn-Ca clip by in vivo micro-CT. Histological analysis, minimal observed inflammation, and an only small decrease in the volume of the implanted Mg-Zn-Ca clip confirmed its excellent biocompatibility. FEA using the material data for ductile Mg-Zn-Ca also showed that the clip could occlude the simulated vessel without fracture. In addition, the Mg-Zn-Ca alloy clip successfully occluded the renal vein. Microstructural observations using electron backscattering diffraction confirmed that dynamic recovery occurred during the later stage of plastic deformation of the ductile Mg-Zn-Ca alloy. These results suggest that the developed Mg-Zn-Ca alloy is a suitable material for biodegradable clips. STATEMENT OF SIGNIFICANCE: Since conventional magnesium alloys have not exhibited significant ductility for applying the occlusion of vessels, the alloying of magnesium with essential elements and the control of microstructure by hot extrusion and annealing were conducted. Mechanical characterization revealed that the Mg-Zn-Ca alloy obtained by double extrusion followed by annealing at 673K for 2h possessed a fracture strain over 0.40. The biocompatibility of the alloy was confirmed by investigating its degradation behavior and the response of extraperitoneal tissue around the Mg-Zn-Ca alloy. Finite element analysis using the material data for the ductile Mg-Zn-Ca alloy also showed that the clip could occlude the simulated vessel without fracture. In addition, the Mg-Zn-Ca alloy clip successfully occluded the renal vein. Microstructural observations using electron backscattering diffraction confirmed that dynamic recovery occurred during the later stage of plastic deformation of the ductile Mg-Zn-Ca alloy.
    Jan. 2016, Acta biomaterialia, 29, 468 - 476, English, International magazine
    Scientific journal

  • 大腸癌肝転移に対する肝切除時期についての検討
    吉田 俊彦, 福本 巧, 木戸 正浩, 武部 敦志, 田中 基文, 蔵満 薫, 木下 秘我, 福島 健司, 浦出 剛史, 宗 慎一, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成
    (一社)日本消化器外科学会, Oct. 2015, 日本消化器外科学会雑誌, 48(Suppl.2) (Suppl.2), 188 - 188, Japanese

  • [Long-term survival in a patient receiving multidisciplinary therapy for hepatocellular carcinoma with left iliac bone metastasis].
    Shinichi So, Masahiro Kido, Takumi Fukumoto, Atsushi Takebe, Motofumi Tanaka, Hisoka Kinoshita, Kaori Kuramitsu, Daisuke Tsugawa, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Sadaki Asari, Taro Okazaki, Makoto Shinzeki, Ippei Matsumoto, Tetsuo Ajiki, Yonson Ku
    The patient was a 79-year-old man diagnosed with a single 9.3-cm hepatocellular carcinoma (HCC) in the medial segment of the liver, and left iliac bone metastasis. Initially, the patient was treated with a hepatic arterial infusion of low-dose FP (cisplatin/5-fluorouracil) at another hospital. Here, the patient received particle therapy for the left iliac bone metastasis at a total dose of 52.8 Gy in 4 fractions. Subsequently, he underwent medial segmentectomy of the liver to treat the primary HCC. Eleven months later, the first intrahepatic recurrence occurred, and the tumor was treated with percutaneous radiofrequency ablation (RFA). A second intrahepatic recurrence was detected 39 months later, which was also treated with percutaneous RFA. The patient remains well, with no evidence of tumor recurrence.
    Nov. 2014, Gan to kagaku ryoho. Cancer & chemotherapy, 41(12) (12), 2107 - 9, Japanese, Domestic magazine
    [Refereed]
    Scientific journal

  • [A case of resection of a metastatic liver tumor that recurred after particle beam therapy].
    Toshihiko Yoshida, Atsushi Takebe, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Daisuke Tsugawa, Kenji Fukushima, Takeshi Urade, Shinichi So, Tetsuo Ajiki, Ippei Matsumoto, Makoto Shinzeki, Taro Okazaki, Sadaki Asari, Tadahiro Goto, Taku Matsumoto, Yonson Ku
    Recently, the indications for particle beam therapy have been expanded to include metastatic liver tumors. However, its adverse effects on the treated liver are unclear, and the possibility of local recurrence after treatment should not be ignored. A 65-year-old man with advanced rectal carcinoma underwent low anterior resection. Resectable metastatic liver tumors were detected after adjuvant chemotherapy; however, he opted to undergo particle beam therapy. Nine months after treatment, a local recurrence was detected around the treated area, and central bisegmentectomy of the liver was performed as a salvage operation. The operation was technically complicated owing to severe adhesions and inflammatory changes in the liver parenchyma around the treated area. Pathological examination revealed advanced liver fibrosis at the treated area, in contrast with normal parenchyma in the untreated area. Although the procedure requires advanced surgical techniques, salvage surgery is a feasible option for recurrent liver tumors after particle beam therapy.
    Nov. 2014, Gan to kagaku ryoho. Cancer & chemotherapy, 41(12) (12), 2071 - 3, Japanese, Domestic magazine
    [Refereed]
    Scientific journal

  • 宗 慎一, 木戸 正浩, 福本 巧, 武部 敦志, 田中 基文, 木下 秘我, 蔵満 薫, 津川 大介, 福島 健司, 浦出 剛史, 吉田 俊彦, 浅利 貞毅, 岡崎 太郎, 新関 亮, 松本 逸平, 味木 徹夫, 具 英成
    (株)癌と化学療法社, Nov. 2014, 癌と化学療法, 41(12) (12), 2107 - 2109, Japanese

  • 吉田 俊彦, 武部 敦志, 福本 巧, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 津川 大介, 福島 健司, 浦出 剛史, 宗 慎一, 味木 徹夫, 松本 逸平, 新関 亮, 岡崎 太郎, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成
    (株)癌と化学療法社, Nov. 2014, 癌と化学療法, 41(12) (12), 2071 - 2073, Japanese

  • [The role of preoperative percutaneous isolated hepatic perfusion and hepatectomy in multidisciplinary treatment].
    Toshihiko Yoshida, Masahiro Kido, Takumi Fukumoto, Shohei Komatsu, Masanori Takahashi, Atsushi Takebe, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Tetsuo Ajiki, Ippei Matsumoto, Makoto Shinzeki, Taro Okazaki, Sadaki Asari, Yonson Ku
    We report a case of multiple bilobar hepatocellular carcinoma( HCC) that was successfully treated with a multidisciplinary treatment including preoperative percutaneous isolated hepatic perfusion and hepatectomy. The patient was a 61- year-old man who was detected as having HCC mainly in segment 4 and 8 of the liver and multiple bilobar intrahepatic metastasis during follow-up evaluation for chronic hepatitis B. Curative resection was difficult because the patient had insufficient liver function and because of the location of the tumor. Hence, we performed preoperative percutaneous isolated hepatic perfusion (PIHP) to control the multiple HCC. Seven weeks after the PIHP, the tumor size had reduced, and therefore we performed an extended left hepatic lobectomy. In addition to these treatment modalities, we performed transcatheter arterial chemoembolization (TACE) 3 times owing to recurrent HCC in the right liver lobe. Considering that HCC in segment 8 can be treated with TACE, we performed partial hepatectomy. As of the last follow-up visit, the patient was alive without disease recurrence. Thus, preoperative PIHP may improve the resectability rate in patients with multiple bilobar HCC for which curative resection is difficult to perform.
    Nov. 2013, Gan to kagaku ryoho. Cancer & chemotherapy, 40(12) (12), 1822 - 4, Japanese, Domestic magazine
    [Refereed]
    Scientific journal

  • 吉田 俊彦, 木戸 正浩, 福本 巧, 小松 昇平, 高橋 応典, 武部 敦志, 田中 基文, 蔵満 薫, 木下 秘我, 味木 徹夫, 松本 逸平, 新関 亮, 岡崎 太郎, 浅利 貞毅, 具 英成
    (株)癌と化学療法社, Nov. 2013, 癌と化学療法, 40(12) (12), 1822 - 1824, Japanese

■ MISC
  • 肝細胞癌におけるArl4c発現の臨床的意義についての検討
    権 英寿, 吉田 俊彦, 木戸 正浩, 田中 基文, 小松 昇平, 粟津 正英, 宗 慎一, 津川 大介, 椋棒 英世, 寺井 祥雄, 柳本 泰明, 外山 博近, 福本 巧
    日本臨床外科学会, Oct. 2019, 日本臨床外科学会雑誌, 80(増刊) (増刊), 461 - 461, Japanese

  • 脳死肝移植後の虚血性胆管障害の治療経過中に肝門部胆管癌を発症した一例
    田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 荒井 啓輔, 福本 巧
    (一社)日本移植学会, Nov. 2017, 移植, 52(4-5) (4-5), 442 - 443, Japanese

  • 術中Shear Wave Elastgraphyによる肝硬度測定と肝繊維化診断
    荒井 啓輔, 田中 基文, 木戸 正浩, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 椋棒 英世, 寺井 祥雄, 松本 拓, 浅利 貞毅, 外山 博近, 楠木 信也, 味木 徹夫, 福本 巧
    (一財)日本消化器病学会, Sep. 2017, 日本消化器病学会雑誌, 114(臨増大会) (臨増大会), A736 - A736, Japanese

  • 肝切除におけるシミュレーションおよびナビゲーション技術の最前線 肝切除における術中超音波を用いた胆道ナビゲーションサージャリーの現状と将来展望
    浦出 剛史, 福本 巧, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 小松 昇平, 津川 大介, 吉田 俊彦, 荒井 啓輔, 外山 博近, 味木 徹夫, 黒田 大介, 具 英成
    (一社)日本外科学会, Apr. 2017, 日本外科学会定期学術集会抄録集, 117回, SY - 3, Japanese

  • C型慢性肝炎に対するDAA治療 肝細胞癌根治切除例の検討
    荒井 啓輔, 田中 基文, 福本 巧, 木戸 正浩, 木下 秘我, 蔵満 薫, 小松 昇平, 津川 大介, 吉田 俊彦, 寺井 祥雄, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 楠 信也, 味木 徹夫, 具 英成
    (一財)日本消化器病学会, Mar. 2017, 日本消化器病学会雑誌, 114(臨増総会) (臨増総会), A367 - A367, Japanese

  • 進行肝細胞癌に対する術前化学療法としての経皮的肝灌流化学療法(PIHP)
    田中 基文, 福本 巧, 木戸 正浩, 木下 秘我, 蔵満 薫, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 寺井 祥雄, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 楠 信也, 味木 徹夫, 具 英成
    (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PS - 5, Japanese

  • 硬変肝を背景とした肝細胞癌に対する肝切除の意義
    吉田 俊彦, 武部 敦志, 福本 巧, 楠 信也, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 宗 慎一, 荒井 啓輔, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成
    (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PS - 3, Japanese

  • 進行肝癌(門脈内腫瘍栓、両葉多発)に対する治療戦略の最前線 多発進行肝癌に対する集学的治療
    木戸 正浩, 福本 巧, 武部 敦志, 田中 基文, 木下 秘我, 蔵満 薫, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成
    (一社)日本外科学会, Apr. 2016, 日本外科学会定期学術集会抄録集, 116回, PD - 1, Japanese

  • Piggyback法を用いた脳死肝移植術後outflow blockに対し下大静脈・肝静脈ステントを挿入した一例
    田中 基文, 福本 巧, 蔵満 薫, 木戸 正浩, 武部 敦志, 木下 秘我, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 具 英成
    (一社)日本移植学会, Oct. 2015, 移植, 50(4-5) (4-5), 507 - 507, Japanese

  • 生体肝移植後早期に脂肪性肝炎を呈した1例
    吉田 俊彦, 福本 巧, 蔵満 薫, 全 陽, 木下 秘我, 田中 基文, 武部 敦志, 木戸 正浩, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 伊藤 智雄, 具 英成
    (一社)日本移植学会, Oct. 2015, 移植, 50(4-5) (4-5), 550 - 550, Japanese

  • 肝胆道手術におけるイノベーション ソナゾイド術中超音波下胆道造影を用いた胆道ナビゲーション
    荒井 啓輔, 福本 巧, 田中 基文, 木戸 正浩, 武部 敦志, 蔵満 薫, 木下 秘我, 松本 拓, 宋 慎一, 吉田 俊彦, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成
    日本臨床外科学会, Oct. 2015, 日本臨床外科学会雑誌, 76(増刊) (増刊), 580 - 580, Japanese

  • 直腸GIST術後肝外巨大発育をきたしたImatinib耐性肝転移の一切除例
    岡本 大輝, 田中 基文, 木戸 正浩, 武部 敦志, 蔵満 薫, 木下 秘我, 宗 慎一, 吉田 俊彦, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 福本 巧, 具 英成
    日本臨床外科学会, Oct. 2015, 日本臨床外科学会雑誌, 76(増刊) (増刊), 1071 - 1071, Japanese

  • 若手移植医が考える、移植医療の未来 肝移植医養成における現状と課題
    蔵満 薫, 福本 巧, 木戸 正浩, 武部 敦志, 田中 基文, 木下 秘我, 宗 慎一, 吉田 俊彦, 荒井 啓輔, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成
    (一社)日本移植学会, Sep. 2015, 移植, 50(総会臨時) (総会臨時), 191 - 191, Japanese

  • 肝胆膵外科周術期のドレーン管理の理想と現実 肝切除後のドレーン留置は必要か? 術後胆汁漏リスク因子からの検討
    吉田 俊彦, 武部 敦志, 福本 巧, 楠 信也, 木戸 正浩, 田中 基文, 蔵満 薫, 木下 秘我, 福島 健司, 浦出 剛史, 宗 慎一, 味木 徹夫, 外山 博近, 浅利 貞毅, 後藤 直大, 松本 拓, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2015, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 27回, 397 - 397, Japanese

  • 肝上部巨大腫瘍に対する開縦隔アプローチを用いた肝切除
    武部 敦志, 福本 巧, 吉田 俊彦, 宗 慎一, 浦出 剛史, 木下 秘我, 蔵満 薫, 田中 基文, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2015, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 27回, 453 - 453, Japanese

  • 肝細胞癌肝切除例における胆汁漏危険因子の検討
    田中 基文, 福本 巧, 木戸 正浩, 武部 敦志, 蔵満 薫, 木下 秘我, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 楠 信也, 味木 徹夫, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2015, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 27回, 499 - 499, Japanese

  • 当科における混合型肝癌切除症例20例の検討
    宗 慎一, 木戸 正浩, 田中 基文, 福本 巧, 楠 信也, 武部 敦志, 木下 秘我, 蔵満 薫, 福島 健司, 浦出 剛史, 吉田 俊彦, 味木 徹夫, 外山 博近, 浅利 貞毅, 松本 拓, 後藤 直大, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2015, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 27回, 511 - 511, Japanese

  • 肝胆膵 術後肝不全を合併しない肝切除術式の選択方法
    蔵満 薫, 福本 巧, 宗 慎一, 吉田 俊彦, 木下 秘我, 田中 基文, 武部 敦志, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 木戸 正浩, 味木 徹夫, 具 英成
    (一社)日本外科学会, Apr. 2015, 日本外科学会定期学術集会抄録集, 115回, OP - 4, Japanese

  • 改正臓器移植法施行から5年 脳死移植は普及したのか? 基礎研究・移植再生 臓器移植法改正後の急性肝不全に対する肝移植
    武部 敦志, 福本 巧, 吉田 俊彦, 宗 慎一, 浦出 剛史, 福島 健司, 木下 秘我, 蔵満 薫, 田中 基文, 木戸 正浩, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成
    (一社)日本外科学会, Apr. 2015, 日本外科学会定期学術集会抄録集, 115回, SY - 4, Japanese

  • 局所治療後再発性肝癌に対する肝切除
    武部 敦志, 福本 巧, 吉田 俊彦, 宗 慎一, 木下 秘我, 蔵満 薫, 田中 基文, 木戸 正浩, 松本 拓, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成
    日本臨床外科学会, Oct. 2014, 日本臨床外科学会雑誌, 75(増刊) (増刊), 455 - 455, Japanese

  • 生体肝移植後胆管狭窄に対し、磁石圧迫吻合術にて狭窄部の開通を得た一例
    宗 慎一, 武部 敦志, 福本 巧, 木戸 正浩, 田中 基文, 木下 秘我, 蔵満 薫, 福島 健司, 浦出 剛史, 吉田 俊彦, 後藤 直大, 浅利 貞毅, 外山 博近, 味木 徹夫, 具 英成
    日本臨床外科学会, Oct. 2014, 日本臨床外科学会雑誌, 75(増刊) (増刊), 483 - 483, Japanese

  • 肝内胆管癌切除例における切離断端陽性リスクの検討
    武部 敦志, 味木 徹夫, 吉田 俊彦, 宗 慎一, 福島 健司, 村上 冴, 木下 秘我, 蔵満 薫, 田中 基文, 浅利 貞毅, 岡崎 太郎, 新関 亮, 木戸 正治, 松本 逸平, 福本 巧, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2014, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 26回, 431 - 431, Japanese

  • 肝切除における当科の術前シミュレーションの現状
    田中 基文, 福本 巧, 木戸 正浩, 武部 敦志, 蔵満 薫, 木下 秘我, 津川 大介, 福島 健司, 浦出 剛史, 宗 慎一, 吉田 俊彦, 岡崎 太郎, 浅利 貞毅, 後藤 直大, 新関 亮, 松本 逸平, 味木 徹夫, 具 英成
    (一社)日本肝胆膵外科学会, Jun. 2014, 日本肝胆膵外科学会・学術集会プログラム・抄録集, 26回, 661 - 661, Japanese

■ Lectures, oral presentations, etc.
  • Comprehensive analysis of altered lipid and amino acid metabolism in patients undergoing pancreatoduodenectomy
    Nanno Y, Toyama H, Ishida J, Mizumoto T, Akita M, Arai K, Tai K, Yoshida T, So S, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Yanagimoto H, Kido M, Fukumoto T
    APA/JPS/CAP/IAP 2024, Dec. 2024, Japanese, International conference
    Oral presentation

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Dec. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Nov. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Nov. 2024, Japanese, Domestic conference
    Public symposium

  • Postoperative complications assessed by the comprehensive complication index (CCI) are associated with early recurrence after curative resection for biliary tract cancer
    Okazoe Y, Yanagimoto H, Akita M, Tsugawa D, Arai K, Yoshida T, So S, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Fukumoto T
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • Clinical Significance of Laparoscopic 0-mm Margin Liver Resection for Vascular in Patients with Hepatocellular Carcinoma
    Shimura Y, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Arai K, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    楠原 達樹, 小松 昇平, 徳丸 直郎, 寺嶋 千貴, 木戸 正浩, 権 英寿, 福島 健司, 浦出 剛史, 吉田 俊彦, 荒井 啓輔, 秋田 真之, 石田 潤, 南野 佳英, 津川 大介, 浅利 貞毅, 柳本 泰明, 外山 博近, 沖本 智昭, 福本 巧
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Oct. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    浦出 剛史, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Tai K, Arai K, Oji K, Fukumoto T
    ILLS2024, Oct. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Sep. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Sep. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Sep. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Sep. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Public symposium

  • Textbook outcomes in initial liver resection for hepatocellular carcinoma: a study with malnutrition grade by the GLIM criteria.
    Oji K, Urade T, Omiya S, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    The 14th Asia-Pacific Primary Liver Cancer Expert Meeting 2024 (APPLE), Jul. 2024, Japanese, International conference
    Poster presentation

  • Clinical significance of hepatectomy for Hepatocellular Carcinoma Associated with Lymph Node and/or Distant Metastases
    Fukushima K, Komatsu S, Kido M, Gon H, Urade T, So S, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T
    The 14th Asia-Pacific Primary Liver Cancer Expert Meeting 2024 (APPLE), Jul. 2024, Japanese, International conference
    Poster presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jul. 2024, Japanese, Domestic conference
    Public symposium

  • -
    Koizumi A, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T
    -, Jun. 2024, Japanese, Domestic conference
    Public symposium

  • Clinical significance of hepatectomy for hepatocellular carcinoma associated with lymph node and/ or distant metastases
    Fukushima K, Komatsu S, Kido M, Gon H, Urade T, So S, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T
    -, Jun. 2024, Japanese, Domestic conference
    Public symposium

  • Treatment outcomes of hepatectomy and systemic chemotherapy based on the oncological criteria of resectability
    Komatsu S, Ishihara N, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T
    -, Jun. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, English, International conference
    Poster presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, May 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2024, Japanese, Domestic conference
    Oral presentation

  • Utility of ALBI grade for predicting prognoses in patients who underwent repeat hepatectomy
    Kusuhara T, Gon H, Kido M, Komatsu S, Fukushima K, Urade T, So S, Yoshida T, Arai K, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, Domestic conference
    Poster presentation

  • Multidisciplinary treatment strategy for macroscopic portal vein tumor thrombus
    Komatsu S, Yano Y, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Ishihara N, Yanagimoto H, Toyama H, Ueda Y, Fukumoto T
    The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, Domestic conference
    Poster presentation

  • A comparative study of laparoscopic liver resection for the segment 4 superior and inferior area
    Koizumi A, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, Domestic conference
    Oral presentation

  • The Efficacy of Total Tumor Volume in Patients with Colorectal Liver Metastases
    Shimura Y, Komatsu S, Fujisawa A, Kido M, Gon H, Fukushima K, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Fukumoto T
    The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver (APASL2024), Mar. 2024, English, Domestic conference
    Oral presentation

  • -
    -
    -, Feb. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jan. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jan. 2024, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Dec. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, English, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Nov. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Sep. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Sep. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Sep. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Sep. 2023, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Sep. 2023, English, Domestic conference
    Oral presentation

  • A comparative study of laparo-scopic liver resection for the segment 8 dorsal and ventral area
    Oji K, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    4th World Congress of International Laparoscopic liver Society（ILLS）, Sep. 2023, English, International conference
    Oral presentation

  • Short-term impact of laparoscopic liver resection with 0-mm surgical margin for HCC
    Shimura Y, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Tsugawa D, Yanagimoto H, Toyama H, Fukumoto T
    4th World Congress of International Laparoscopic liver Society（ILLS）, Sep. 2023, English, International conference
    Oral presentation

  • Acceptability of Laparoscopic Liver Resection of Segment I: A Retrospective Study
    Fujinaka R, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    4th World Congress of International Laparoscopic liver Society（ILLS）, Sep. 2023, English, International conference
    Oral presentation

  • Laparoscopic segmentectomy2 versus left lateral sectionecto-my for liver tumors in segment2
    Urade T, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Omiya S, Shimura Y, Yanagimoto H, Toyama H, Fukumoto T
    4th World Congress of International Laparoscopic liver Society（ILLS）, Sep. 2023, English, International conference
    Oral presentation

  • Impact of malnutrition diagnosed by the GLIM criteria on postoperative complications after pancreaticoduodenectomy for biliary tract cancer
    Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Okawa T, Omiya S, Arai K, Yoshida T, So S, Ishida J, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T
    45th ESPEN Congress, Sep. 2023, English, International conference
    Poster presentation

  • Impact of malnutrition diagnosed by the GLIM criteria on outcome of elderly patients with hepatocellular carcinoma after liver resection
    Omiya S, Urade T, Komatsu S, Kido M, So S, Gon H, Fukushima K, Yoshida T, Arai K, Okazoe Y, Akita M, Ishida J, Nanno Y, Tsugawa D, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    45th ESPEN Congress, Sep. 2023, English, International conference
    Poster presentation

  • -
    -
    -, Sep. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jul. 2023, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jul. 2023, Japanese, Domestic conference
    Oral presentation

  • A study for infectious complication of hepatectomies in patients with preexisting bilioenteric anastomosis
    Oji K, Urade T, Kido M, Kuramitsu K, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Poster presentation

  • Successful biliary drainage using hybrid EUS-BD for stricture of choledochojejunostomy
    Tsugawa D, Yanagimoto H, Akita M, Arai K, Yoshida T, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Kuramitsu K, Goto T, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Poster presentation

  • Intended destination for a board certified surgeon under 45
    Arai K, Komatsu S, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yoshida T, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Oral presentation

  • Prognostic significance of malnutrition diagnosed by the GLIM criteria for resected extrahepatic cholangiocarcinoma: A single-center retrospective study
    Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Omiya S, Arai K, Yoshida T, So S, Ishida J, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Kuramitsu K, Goto T, Asari S, Toyama H, Kido M, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Oral presentation

  • The optimal treatment strategy of therapeutic intervention using total tumor volume in patients with colorectal liver metastases
    Shimura Y, Komatsu S, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Goto T, Yanagimoto H, Toyama H, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Oral presentation

  • Improvement in stapler pancreatic transection to reduce pancreatic fistula after laparoscopic distal pancreatectomy: twelve-year experience at a single high-volume center
    Ishida J, Toyama H, Asari S, Goto T, Nanno Y, Fukuoka H, Ami K, Akita M, Arai K, Yoshida T, So S, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Yanagimoto H, Kido M, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Oral presentation

  • Anterior approach for open rigththepatectomy for huge hepatocellular carcinoma
    Urade T, Kido M, Kuramitsu K, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Arai K, Omiya S, Fujinaka R, Akita M, Ishida J, Nanno Y, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T
    -, Jun. 2023, English, Domestic conference
    Public symposium

  • -
    -
    -, Jun. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Jun. 2023, Japanese, Domestic conference
    Public symposium

  • -
    -
    -, Jun. 2023, Japanese, Domestic conference
    Public symposium

  • The factors of predicting over-time weight increase after liver transplantation
    Shimura Y, Kuramitsu K, Kido M, Komatsu S, Gon H, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Goto T, Asari S, Yanagimoto H, Toyama H, Fukumoto T
    ILTS2023, May 2023, English, International conference
    Poster presentation

  • Indication of liver transplantation in the treatment of newly categorized acute-on-chronic liver failure in Japan
    Kuramitsu K, Komatsu S, Kido M, Tsugawa D, Gon H, Fukushima K, Goto T, Yanagimoto H, So S, Arai K, Yoshida T, Ajiki T, Toyama H, Fukumoto T
    ILTS2023, May 2023, English, International conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Poster presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

  • -
    -
    -, Apr. 2023, Japanese, Domestic conference
    Oral presentation

TOP